Commentaries

When a Stem Cell Transplant Protects a Child’s Brain for a Decade: What the DREPAGREFFE Trial Tells Us

Could a transplant shield a child’s brain from silent damage compared to standard care? A 10-year study has some answers.

What Is DLBCL, and How Is It Treated in 2026? Here Is What the Latest Evidence Says

Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive blood cancer. From chemo to engineered immune cells, here is what patients need to know in 2026.

Should all polycythemia vera patients start on interferon?

A major review in Leukemia argues the evidence now supports using interferon-alpha as first-line therapy for nearly all PV patients — from diagnosis, not as a last resort.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Secret Link